About admin

This author has not yet filled in any details.
So far admin has created 30 blog entries.

Elsevier Publication – Health Economics

Dr. Ariel Beresniak, CEO and founder of Data Mining International and Gérard Duru, Senior Research Partner of Data Mining International,
have co-authored with Elsevier, the publication “Economie de la Santé”.

The publication “Economie de la Santé” presents the stakes within health economics, and the methods and tools for economic health evaluations, for estimating the value of innovations in health and for finding the balance between solidarity and freedom.

The publication is structured as follows:

  1. The health systems within the European Union.
  2. Health planning.
  3. A study of supply and demand in health.
  4. Health expenses.
  5. The control of costs.
  6. The methods and tools of economic […]
2020-09-02T12:30:53+02:00September 2nd, 2020|Categories: Publications|Tags: , , , , , |

The Lancet – Les Tromperies de la Renommée

Dr. Ariel Beresniak, CEO and founder of Data Mining International reviews in this article in Causeur magazine, the highly controversial situation where the internationally reputed scientific journal The Lancet took its distance from the study it had previously published on the dangers of chloroquine.

Please click on the image for access to the full article:

2020-09-02T12:29:30+02:00June 6th, 2020|Categories: Articles|Tags: , , , |

Cost of human life during COVID pandemic

Dr. Ariel Beresniak presents an analysis behind economic decisions being made amidst Covid-19, in this article for Causeur Magazine in May 2020.


Please click on the image for access to the full article:

2020-07-31T18:05:49+02:00May 18th, 2020|Categories: Articles|

Hydroxychloroquine in COVID: What is a “proof” ?

During unsettling Covid-19 times of emergency, Dr. Ariel Beresniak puts science back to its rightful place as a benchmark for decision-making, in this article published in Causeur magazine on 4th May 2020.

Please click on the image for access to the full article:

2020-07-31T18:08:35+02:00May 4th, 2020|Categories: Articles|

Test-and-treat strategy using Urea Breath Tests is cost-effective in managing symptoms and consequences from Helicobacter Pylori infection

Test-and-treat strategy using Urea Breath Tests is proven to be cost-effective in managing symptoms and consequences from Helicobacter pylori infection, thus contributing to preventing peptic ulcer and gastric cancer.

For more information regarding this subject please refer to our Press Release.

2020-07-31T11:49:09+02:00February 4th, 2019|Categories: Articles|

USING UREA BREATH TESTS IS PROVEN TO BE A COST-EFFECTIVE METHOD FOR MANAGING SYMPTOMS AND CONSEQUENCES OF HELICOBACTER PYLORI BACTERIA INFECTION

Almost 60% of the world population is infected with the Helicobacter pylori bacteria: a new study establishes that a test-and-treat strategy using Urea Breath Tests is cost-effective in managing symptoms and consequences from this infection, thus contributing to prevent peptic ulcer and gastric cancer.

Helicobacter pylori infection is a major public health issue affecting 60% of the world’s population with 90% of Peptic Ulcer attributed to and 80% of Gastric Cancers associated with Hp infection.

With the support of an international expert panel composed of […]

2020-07-31T17:33:15+02:00November 27th, 2018|Categories: Press releases|

DMI presents the QALYs’ inadequacies during the Ethics Prize Seminar in Stockholm

Dr Ariel Beresniak took part in the Ethics Prize Seminar in Stockholm in October 2016, where he discussed once again how inadequate, inaccurate and unethical the QALY approach is when used for making a decision about new medicines’ access to patients in need. 

This seminar was organised by the Swedish Council of Medical Ethics.

The full seminar broadcast can be viewed here. Dr Ariel Beresniak’s presentation starts at 1:50:13.

More information on the QALYs and DMI’s role in the ECHOUTCOME project: www.echoutcome.eu.

2020-07-31T11:49:09+02:00December 19th, 2016|Categories: Articles|

New publication related to the EHR4CR project on the re-use of the electronic health data

The European research project Electronic Health Records for Clinical Research (EHR4CR) was co-funded by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the Innovative Medicines Initiative. A new budgetary impact assessment published in the Journal of Health & Medical Informatics reveals that compared to current practices, the EHR4CR platform appears cost-saving for pharmaceutical industry, the primary sponsor of clinical trials.

 

The full article is available here.

More information on the EHR4CR project: www.ehr4cr.eu.

2020-07-31T11:49:09+02:00August 9th, 2016|Categories: Articles|

Public Health promoted by Classical Music – a concert-conference hosted by DMI in the frame of the ASSET project

It is a well-known fact how music positively affects the intellectual development and improves the concentration. This relationship, appreciated by musicians and music fans is gradually gaining more attention also from the scientific research teams around the world. The scientific consortium ASSET, financed by the European Commission, proposes a unique way of integrating classical music in the promotion of public health by organising a piano concert where the classical piano pieces will be accompanied by the presentations of six international scientific experts.

“Concerto for Piano and Sciences” is the first event of this kind […]

2020-07-31T11:49:09+02:00July 13th, 2016|Categories: Articles|